From the atomic nucleus to man Nuclear magnetic resonance spectroscopy, the next horizon in diagnostic cardiology**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology. by Pohost, Gerald M. & Forder, John R.
EDITORIAL COMMENT
From the Atomic Nucleus to Man
Nuclear Magnetic Resonance
Spectroscopy, the Next
Horizon in Diagnostic Cardiology*
Gerald M. Pohost, MD, FACC,
John R. Forder, PHD
Los Angeles, California
The study by Nakae et al. (1) in this issue of the Journal
presents compelling evidence suggesting a role for (nuclear)
magnetic resonance (MR) spectroscopy to assess heart
failure in the future. No longer relegated clinically to only
providing finely detailed anatomical images, the full poten-
tial of MR techniques is the ability to visualize biochemical
and physiological processes. With respect to physiologic
processes, it is the ability of MR to rapidly image ventricular
volumes and wall motion, to evaluate viability, to assess
arterial morphology and plaque, and to evaluate myocardial
perfusion. In the case of biochemical processes, it is the
ability of MR to perform spectroscopy and evaluate myo-
cardial metabolism (without the use of radionuclides).
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Unlike phosphorus (31P) or sodium (23Na) protons, the
hydrogen nucleus, or 1H, can be very sensitively detected by
MR spectroscopic methods. The proton has the highest
magnetic moment of all biologically relevant nuclei. As a
result, the volume of interest that is interrogated can be
smaller, and the confounding influence of signals from
outside this volume can be minimized. In addition, the
increased sensitivity of the hydrogen nucleus means that the
entire heart can be evaluated, not just the anterior and
anteroseptal walls of the left ventricle, as is presently the case
with clinical phosphorus spectroscopy to evaluate myocar-
dial high-energy phosphate metabolism.
The role of myocardial phosphocreatine (PCr) as an
energy shuttle (2,3) remains somewhat controversial. Recent
proponents argue for a role of PCr in the transfer of energy
from the mitochondria to the myofibrils under conditions of
high workload (4,5), while others point to the functional
stability of hearts from transgenic mice without creatine
phosphokinase (CPK) (6) and the diffusional mobility of
PCr being equivalent to that of adenosine triphosphate
(ATP). However, there is no doubt that PCr serves as a
storage depot for ATP repletion during times of stress. This
reaction, which repletes ATP, is normally at equilibrium in
myocardial cells, and the reaction proceeds as the result of
mass action—that is, the concentrations of the reactive
products determine the steady-state concentrations that
result. As ATP is hydrolyzed to adenosine diphosphate
(ADP), the increased concentration of ADP drives the
reaction to favor the hydrolysis of PCr to creatine to
regenerate the ATP. Likewise, alterations in the concentra-
tion of creatine directly impact the resulting concentrations
of PCr—more creatine means more PCr, whereas less
creatine means less PCr (in the resting state). The impact of
a lower PCr concentration is evident, especially under
conditions of metabolic stress or ischemia. However, the
preponderance of clinical measures of PCr and ATP rely
upon the ratio of these two important bioenergetic mole-
cules. Because this relationship is close to equilibrium,
changes in the ratio only occur when the myocardium
undergoes rapid change in energy utilization. In contrast,
quantitative measurement of the metabolites under the same
conditions may reveal a decline in the pool sizes and a
significant decline in the ability of the myocardium to
survive periods of ischemia.
Although MR spectroscopic techniques hold great clini-
cal promise, they have not found widespread application.
The application of 1H spectroscopy to the heart has pro-
vided a means to quantitate myocardial lipids. In this
scenario increased concentrations of lipid provide evidence
of myocardial ischemia vis-a`-vis the inability to aerobically
metabolize lipids (7). However, because the heart is gener-
ally bathed in a pool of similar lipids, the lipid in the
myocardial walls adjacent to the pericardial fat is presently
difficult to assess. Only the interventricular septum is free of
the confounding effects of the pericardial lipid. Research
models have used 1H spectroscopy to assess the oxygenation
status of myocardial myoglobin in an effort to determine the
severity of an ischemic event (8,9), but this has not yet been
clinically applied. Recent work by Bottomley and co-
workers (10) showed decreased concentrations of creatine in
areas of infarcted myocardium using 1H spectroscopy,
although the progression of creatine loss as a function of the
stage of infarction was not possible in their study. Although
recent results using 31P-NMR spectroscopy at rest and with
stress have suggested that this technique has the ability to
identify myocardial ischemia in the absence of epicardial
coronary artery disease, perhaps at the microvascular level
(11), and the presence of such stress-induced data portend a
worse prognosis in women with chest pain, further data are
needed before this approach can become a routine clinical
procedure. Advances in MR scanner hardware have now
made possible the simultaneous acquisition of 31P spectra
with either 1H imaging or spectroscopy, thus decreasing the
time required for these investigations and making new
information available to the clinician.
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The finding that the severity of a cardiomyopathy appears
to be inversely correlated with the amount of creatine poses
an interesting question—does the decrease in creatine cause
(or hasten) the progression of the underlying myocardial
pathology? Or, does the decline in creatine concentration
simply provide a correlative observation? Although the
investigators conclude that noninvasive assessment of myo-
cardial creatine by 1H spectroscopy is useful for the assess-
ment of the severity of heart failure associated with cardio-
myopathy (1), this role might be best served by high-
resolution MR imaging to evaluate ventricular wall motion,
ejection fraction, and volumes. Alternatively, the findings
from the current study (1) suggest the possibility for the
biochemical as opposed to the functional staging of heart
failure. Our own conclusions from this study are that PCr
and creatine may play a substantial causative role underlying
the progression of heart failure in cardiomyopathy. More
importantly, the study by Nakae et al. (1) has demonstrated
the ability of MR methods to traverse the enormous space
from the atomic nucleus (the protons of creatine) to man
(the progression of heart failure associated with cardiomy-
opathy).
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